Navigation Links
Damon Runyon Cancer Research Foundation awards $3.6 M to 9 top young clinical investigators
Date:7/1/2013

NEPC tumors for recurrent molecular alterations and determine their functional and clinical impact. She will identify a genomic profile that distinguishes NEPC from the more common type of prostate cancer, prostate adenocarcinoma, and evaluate the impact of NEPC-associated alterations on patient outcomes and their ability to predict patient response to available therapies. Her goal is to improve our understanding of molecular events associated with disease progression and help develop strategies toward preventing NEPC. Distinguishing NEPC will help identify prostate cancer patients unlikely to benefit from additional AR-targeted strategies and select patients for novel targeted treatment approaches for NEPC.

Dr. Beltran works under the mentorship of Mark A. Rubin, MD, at Weill Medical College of Cornell University, New York, New York.

Christine M. Lovly, MD, PhD

Lung cancer is responsible for more cancer-related deaths in the U.S. and worldwide each year than any other cancer. Historically, patients with advanced metastatic disease have been treated with conventional chemotherapy. Recently, however, subsets of lung cancer patients have been identified with specific molecular alterations that allow for treatment with rationally chosen targeted therapies. One molecular subset of lung cancer is characterized by the presence of alterations in a protein called ALK tyrosine kinase. Patients with lung cancers that harbor ALK fusions derive significant clinical benefit from a newly approved drug that blocks the action of the mutant ALK. Unfortunately, the degree and duration of tumor response to ALK inhibitor drugs varies, and patients inevitably develop progressive disease, or "acquired resistance." Additional strategies are needed to improve the treatment of these lung cancer patients.

Dr. Lovly's goal is to develop novel treatment strategies for ALK positive lung cancer.

She plans to improve our understanding of how ALK fusions
'/>"/>

Contact: Yung S. Lie
yung.lie@damonrunyon.org
212-455-0521
Damon Runyon Cancer Research Foundation
Source:Eurekalert

Page: 1 2 3 4 5 6 7

Related biology news :

1. Damon Runyon Cancer Research Foundation grants prestigious awards to 17 young scientists
2. Damon Runyon-Rachleff Innovation Awards granted for pioneering ideas in cancer research
3. ACRG and BGI report new evidence for the genetic bases of liver cancer
4. Cancer is a result of a default cellular safe mode, physicist proposes
5. Continued research needed on treatment for women with lung cancer who are never smokers
6. TGen and Ventana Medical Systems Inc. join forces to fight cancer
7. National Institutes of Health to fund research probing proteins linked to cancer, diabetes
8. Herding cancer cells to their death
9. No danger of cancer through gene therapy virus
10. An article in Cell reveals a new resistance mechanism to chemotherapy in breast and ovarian cancer
11. Osteoporosis drug stops growth of breast cancer cells, even in resistant tumors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2015)... August 28, 2015 According to ... Market by Assessment Type (Pen & Paper Based, Hosted, ... Corporate Learning, Academic Research), Vertical and Region - Global ... Training Market to grow from USD 2.4 Billion in ... Compound Annual Growth Rate (CAGR) of 25.6% from 2015 ...
(Date:8/20/2015)... PLEASANTON, Calif. , Aug. 20, 2015 /PRNewswire/ ... focused on consumers that are active and healthy. ... used in the hospital environment to help improve ... released a video from the Wearable Technologies ... MD discussed new applications for wearables in healthcare.    ...
(Date:8/18/2015)... 2015 Research and Markets ( http://www.researchandmarkets.com/research/9dmm6l/global_biometric ... "Global Biometric Authentication & Identification Market: Focus On ... 2015-2020" report to their offering. ... market is expected to grow at an estimated ... generate over $25 billion (approximately) by 2020 as ...
Breaking Biology News(10 mins):Cognitive Assessment and Training Market Worth 7.5 Billion USD by 2020 2Cognitive Assessment and Training Market Worth 7.5 Billion USD by 2020 3Cognitive Assessment and Training Market Worth 7.5 Billion USD by 2020 4Leaf Healthcare Releases Video from Wearable Technology Conference on New Applications for Wearables in the Hospital Environment 2Leaf Healthcare Releases Video from Wearable Technology Conference on New Applications for Wearables in the Hospital Environment 3Global Biometric Authentication & Identification Market 2015: Focus On Modality, Motility & Application - Estimation & Forecasts to 2020 for the $25 Billion Industry 2
... Researchers in Finland think so. A new study published ... relationships with plants and recommends horticultural interventions, especially for ... its forests and wilderness, researchers Taina Laaksoharju from ... Helsinki and Erja Rappe of The Martha Association teamed ...
... live longer. The price we pay: infectious diseases can ... immune system does not function flawlessly in old age. ... and two companies is investigating why our immune defence ... "GERONTOSHIELD", funded by the German Federal Ministry of Education ...
... Boston, MA - Tiny particles only billionths of a meter in ... haircould offer big hope in a small package to the many ... from jewelry to coins and cell phones, say scientists at Brigham ... of Nature Nanotechnology, the team will report a new ...
Cached Biology News:Researchers say children need horticultural interventions 2A better understanding of the aging immune system 2Nanoparticles offer hope for common skin allergy 2Nanoparticles offer hope for common skin allergy 3
(Date:9/2/2015)... DUBLIN , Sep. 02, 2015 ... announced the addition of Jain PharmaBiotech,s new report ... their offering. The markets for gene therapy ... approved gene therapy product and it is marketed in ... markets are estimated for the years 2014-2024. The estimates ...
(Date:9/2/2015)... ... September 02, 2015 , ... Drug companies ... compounds. BCC Research reveals in its new report that the U.S. will ... the category and generates the most market demand. , BCC Research examines ...
(Date:9/2/2015)... -- Aytu BioScience, Inc. (OTCQB: AYTU), a specialty healthcare ... conditions, announced today that it has closed the final ... raising a total of $5.175 million, which includes proceeds ... Josh Disbrow , Chief Executive Officer of ... to be used to conduct clinical studies for both ...
(Date:9/2/2015)... Israel , September 2, 2015 ... announced the intent of the National Institute of Allergy and ... Health (NIH) within the Department of Health and Human Services ... held in the United States in ... BiondVax,s universal flu vaccine candidate, Multimeric-001 (M-001), as a primer ...
Breaking Biology Technology:Global Gene Therapy Market Study 2015-2024 - Technologies, Markets and Companies Analysis 2Plant-derived Compounds Poised to Assume Greater Role in Global Drug Markets, According to BCC Research 2Plant-derived Compounds Poised to Assume Greater Role in Global Drug Markets, According to BCC Research 3Aytu BioScience Completes $5.175 Million Private Placement 2Aytu BioScience Completes $5.175 Million Private Placement 3BiondVax Announces Intent to Launch a Phase 2 Trial in the United States in Collaboration with the U.S. National Institutes of Health 2BiondVax Announces Intent to Launch a Phase 2 Trial in the United States in Collaboration with the U.S. National Institutes of Health 3
... was the soccer-ball-shaped molecules dubbed buckyballs. Then it was ... in physics and nanotechnology is graphene: a remarkably ... rings much like molecular chicken wire. Not ... also is 10 times stronger than steel and it ...
... Conn., Nov. 17 Doctors Research Group, Inc. announced ... U.S. Food and Drug Administration (FDA) to market KRYPTONITE(TM) ... represents a major advancement in treating cranial defects due ... low exotherm cement and bone void filler approved for ...
... Nov. 17 Merriman Curhan Ford Group, Inc. (Nasdaq: ... (OTC Bulletin Board: PYMX) $20.7 million registered public offering of ... per unit, consist of one share of PolyMedix common stock ... share of PolyMedix common stock at $1.25 per share. , ...
Cached Biology Technology:New study confirms exotic electric properties of graphene 2New study confirms exotic electric properties of graphene 3Doctors Research Group Receives FDA Clearance for U.S. Distribution of KRYPTONITE(TM) Bone Cement 2Merriman Curhan Ford Acted as Lead Placement Agent in PolyMedix's $20.7 Million Equity Financing 2
... The versatile ST-195 allows real-time observations ... conditions. This instrument has 64 different strain ... CO2 incubator. The thin silicon strain chamber ... inverted microscopes and fluorescence microscopy. ST-195 can ...
Immunogen GST fusion protein corresponding to full-length rat JNK3/ SAPK1b. Quality Assurance Routinely evaluated by immunoblot. Stability 2 years at -20°C from date of shipment GenBank A...
... Kit is used in conjunction with the EasyCount ... automatically. The ViaSure Staining Reagent uses a ... Orange and Ethidium Bromide to identify live and ... the EasyCount Slide 6 Multi-well Slide provides ...
... Bioconjugation Kit provides a powerful yet simple ... nuceleic acids. The kit provides the heterobifunctional ... for quantifying conjugation efficiencies. It enables conjugation ... and other tags with a variety of ...
Biology Products: